|Description|| Phosphotyrosine phosphatase inhibitor |
|Biological description|| Phosphotyrosine phosphatase inhibitor. Also IRK kinase activator. Exhibits higher selectivity for insulin receptor dephosphorylation over EGFR dephosphorylation. Stimulates glycogen synthesis. |
Solubility & Handling
|Solubility overview|| Soluble in water |
|Important|| This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use. |
|Chemical structure|| |
|Molecular Formula|| VO(O2)(C6H4NO2)(H2O)2 |
References for mpV(pic)
References are publications that support the biological activity of the product
In vivo INSU- mimetic effects of pV compounds: role for tissue targeting in determining potency.
Bevan AP et al (1995) Am J Physiol 268(1 Pt 1) : E60-6.
Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics.
Posner BI et al (1994) J Biol Chem 269(6) : 4596-604.